<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0005">
 <label>Table 1</label>
 <caption>
  <p>Some viral targets of antibodies.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th colspan="5">Therapeutic Applications
     <hr/>
    </th>
   </tr>
   <tr>
    <th>Virus</th>
    <th>Target</th>
    <th>Description</th>
    <th>Efficacy of targeting</th>
    <th>Ref.</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>RSV</td>
    <td>F surface glycoprotein</td>
    <td>This protein carries out an impressive structural rearrangement leading to membrane fusion and plays a key role in RSV infection and pathogenesis.</td>
    <td>Inhibition of viral fusion</td>
    <td>
     <xref rid="b0070" ref-type="bibr">[14]</xref>, 
     <xref rid="b0075" ref-type="bibr">[15]</xref>
    </td>
   </tr>
   <tr>
    <td>Human influenza A virus</td>
    <td>hemagglutinin protein (HA)</td>
    <td/>
    <td/>
    <td>
     <xref rid="b0080" ref-type="bibr">[16]</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="5">HIV-1</td>
    <td>Host viral receptor-CD4</td>
    <td>CD4 molecule contributes to the fusion of cell and viral membranes.</td>
    <td>Interferes with the binding of HIV-1 to its primary receptor on target cells and inhibition of HIV-1 Entry to the host cell</td>
    <td>
     <xref rid="b0085" ref-type="bibr">[17]</xref>
    </td>
   </tr>
   <tr>
    <td>Host viral receptor-CCR5</td>
    <td>CCR5 often acts with CD4 as a co-receptor for the virus.</td>
    <td>Inhibition of HIV-1 Entry to the host cell</td>
    <td>
     <xref rid="b0090" ref-type="bibr">[18]</xref>
    </td>
   </tr>
   <tr>
    <td>Envelope glycoprotein (Env)</td>
    <td>Defined vulnerable epitopes on its surface such as the CD4 binding site and the V3 loop.</td>
    <td>Inhibition of the CD4-binding</td>
    <td>
     <xref rid="b0095" ref-type="bibr">[19]</xref>
    </td>
   </tr>
   <tr>
    <td>gp120</td>
    <td>Mediates attachment of HIV to human CD4 and CCR5 expressing cells.</td>
    <td/>
    <td>
     <xref rid="b0100" ref-type="bibr">[20]</xref>
    </td>
   </tr>
   <tr>
    <td>p24</td>
    <td>HIV-1 capsid protein p24 plays key roles in HIV pathogenesis.</td>
    <td>Inhibition of the replication of HIV-1 in target cells</td>
    <td>
     <xref rid="b0105" ref-type="bibr">[21]</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="2">HBV</td>
    <td>the antigenic loop of HBsAg</td>
    <td>Neutralizing viral entry and blocking the interaction with the pre-receptor heparan sulphate proteoglycan (HSPG).</td>
    <td/>
    <td>
     <xref rid="b0110" ref-type="bibr">[22]</xref>
    </td>
   </tr>
   <tr>
    <td>The preS1 segment of the large envelope glycoprotein</td>
    <td>This segment is essential for virion attachment and infection.</td>
    <td>Inhibition of HBV entry to the host cell</td>
    <td>
     <xref rid="b0115" ref-type="bibr">[23]</xref>
    </td>
   </tr>
   <tr>
    <td>Flaviviruses (such as Zika virus)</td>
    <td>Domain III of E protein</td>
    <td>The E protein has three domains (DI, DII, and DIII) and domain DIII contains the receptor-binding site.</td>
    <td>Inhibition of virus attachment</td>
    <td>
     <xref rid="b0120" ref-type="bibr">[24]</xref>
    </td>
   </tr>
   <tr>
    <td>Coronaviruses
     <list list-type="simple" id="l0005">
      <list-item id="o0005">
       <label>•</label>
       <p id="p0005">SARS-CoV</p>
      </list-item>
      <list-item id="o0010">
       <label>•</label>
       <p id="p0010">MERS-CoV</p>
      </list-item>
      <list-item id="o0015">
       <label>•</label>
       <p id="p0015">SARS-CoV-2</p>
      </list-item>
     </list>
    </td>
    <td>S1 domain of spike glycoprotein</td>
    <td>The S1 domain acts as a major antigen on the surface of the virus and has a receptor‑binding domain (RBD).</td>
    <td>preventing virus attachment to its receptor</td>
    <td>
     <xref rid="b0125" ref-type="bibr">[25]</xref>, 
     <xref rid="b0130" ref-type="bibr">[26]</xref>
    </td>
   </tr>
   <tr>
    <td colspan="5">  </td>
   </tr>
   <tr>
    <td colspan="5">Diagnostic applications</td>
   </tr>
   <tr>
    <td colspan="5">
     <hr/>
    </td>
   </tr>
   <tr>
    <td>Virus</td>
    <td>Target</td>
    <td colspan="2">Description</td>
    <td>Ref.</td>
   </tr>
   <tr>
    <td colspan="5">
     <hr/>
    </td>
   </tr>
   <tr>
    <td>HPV</td>
    <td>HPV L1 protein</td>
    <td colspan="2">L1 protein is a major capsid protein of human papillomavirus. Ani-LI antibody can be valuable in detection and clinical screening of cervical cancer. Detection of HPV in cervical exfoliated cells</td>
    <td>
     <xref rid="b0135" ref-type="bibr">[27]</xref>
    </td>
   </tr>
   <tr>
    <td>Dengue Virus</td>
    <td>NS1</td>
    <td colspan="2">Nonstructural protein 1 is secreted from infected cells as a water soluble hexamer form (sNS1) or as a membrane-associated protein (mNS1). Generally, with the onset of symptoms, NS1 appears in the patient's blood and can be detected before IgM antibodies.</td>
    <td>
     <xref rid="b0140" ref-type="bibr">[28]</xref>
    </td>
   </tr>
   <tr>
    <td>MERS-CoV</td>
    <td>Nucleocapsid protein (NP)</td>
    <td colspan="2">N protein functions in viral RNA genome packaging, viral transcription and assembly. NP is present at high levels in infected cells.</td>
    <td>
     <xref rid="b0145" ref-type="bibr">[29]</xref>
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
